Medico Remedies Limited — Others, 05-08-2025: Shareholders meeting

Medico Remedies Limited submitted its Annual Report for FY25, highlighting a robust financial year. Total income grew to **₹153.63 Cr** from ₹147.04 Cr, with net profit rising to **₹10.09 Cr** from ₹8.29 Cr. The company achieved WHO GMP certification for its manufacturing facilities and initiated construction for a new Beta lactam plant, investing **₹2.83 Cr** in capital expenditure for growth. The upcoming AGM will seek approval for director re-appointments, including the Managing Director and Chairman, and the appointment of a new Executive Director and statutory auditors, signalling leadership continuity and strategic expansion.